Andrew Wasson serving as a panelist for FDLI’s Orange You Glad You Learned About Teva v. Amneal?: A Watershed Case in Orange Book Listing

Partner, Andrew Wasson will be speaking at the upcoming Food and Drug Law Institute webinar: Orange You Glad You Learned About Teva v. Amneal?: A Watershed Case in Orange Book Listing.

The Food and Drug Law Institute (FDLI) is a nonprofit membership organization that offers education, training, publications, and professional engagement opportunities in the field of food and drug law. As a neutral convener, FDLI provides a venue for stakeholders to inform innovative public policy, law, and regulation.

Join us for an in-depth discussion of the impact of Teva v. Amneal—a landmark decision that has changed the Orange Book landscape. Expert panelists will provide context for the case, unpack its implications for FDA policy and enforcement, discuss FTC’s approach to related issues, and examine the case as it relates to antitrust matters within the pharmaceutical industry.

The conference will take place during a live webinar on November 12, from 2-3:30 PM ET. To register for this event and for additional information, click here.